Behavior of alginate gel beads containing chitosan salt prepared with water-soluble vitamins

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 53, Issue 2, 2002, Pages 249-251

  Murata, Y ^a   Kontani, Y ^a   Ohmae, H ^a   Kawashima, S ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Alginate gel bead; Ascorbic acid; Bile acid; Chitosan; Hyperlipidemia

Indexed keywords

ALGINIC ACID; ASCORBIC ACID; CHITOSAN; FOLIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OROTIC ACID; PANTOTHENIC ACID; TAUROCHOLIC ACID;

ARTICLE; BILE; DRUG FORMULATION; DRUG UPTAKE; GEL; HYDROGEL; HYPERLIPIDEMIA;

ALGINATES; BILE ACIDS AND SALTS; BIOCOMPATIBLE MATERIALS; CHEMISTRY, PHARMACEUTICAL; CHITIN; CHITOSAN; CITRIC ACID; FOLIC ACID; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEL; MICROSPHERES; OROTIC ACID; SOLUBILITY; VITAMINS;

EID: 0036191180     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(01)00231-4     Document Type: Article

References (10)

1. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy
2. Higher cholesterol in human LDL is associated with the increase of oxidation susceptibility and the decrease of antioxidant defence: experimental and simulation data
3. Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolaemia or essential hypertension assessed by cold pressor testing
4. In medical aspects of dietary fiber
5. Additive effect of chondroitin sulfate and chitosan on drug release from calcium-induced alginate gel beads
6. The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan
7. The controlled release of a drug from biodegradable chitosan gel beads
8. Preparation of alginate gel beads containing chitosan salt and their function
9. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia
10. Achievement of target plasma cholesterol levels in hypercholesterolaemic patients being treated in general practice